IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 61 filers reported holding IRADIMED CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,705,029 | -2.6% | 83,503 | +4.8% | 0.00% | 0.0% |
| Q2 2023 | $3,803,589 | +22.9% | 79,673 | +1.3% | 0.00% | 0.0% |
| Q1 2023 | $3,095,980 | +40.2% | 78,678 | +0.8% | 0.00% | – |
| Q4 2022 | $2,208,600 | -5.5% | 78,070 | +0.5% | 0.00% | -100.0% |
| Q3 2022 | $2,336,000 | -11.6% | 77,703 | -0.2% | 0.00% | 0.0% |
| Q2 2022 | $2,643,000 | -20.4% | 77,865 | +5.2% | 0.00% | 0.0% |
| Q1 2022 | $3,319,000 | -6.6% | 74,010 | -3.7% | 0.00% | 0.0% |
| Q4 2021 | $3,552,000 | +32.6% | 76,875 | -3.6% | 0.00% | – |
| Q3 2021 | $2,678,000 | +14.0% | 79,722 | -0.2% | 0.00% | – |
| Q2 2021 | $2,350,000 | +11.3% | 79,910 | -2.4% | 0.00% | – |
| Q1 2021 | $2,111,000 | -6.6% | 81,904 | -17.4% | 0.00% | – |
| Q4 2020 | $2,260,000 | +0.3% | 99,160 | -5.9% | 0.00% | – |
| Q3 2020 | $2,253,000 | -9.8% | 105,409 | -2.1% | 0.00% | -100.0% |
| Q2 2020 | $2,499,000 | +20.7% | 107,685 | +11.0% | 0.00% | 0.0% |
| Q1 2020 | $2,071,000 | -0.8% | 96,975 | +8.6% | 0.00% | – |
| Q4 2019 | $2,087,000 | +11.5% | 89,300 | +0.3% | 0.00% | – |
| Q3 2019 | $1,872,000 | +24.9% | 89,018 | +21.5% | 0.00% | – |
| Q2 2019 | $1,499,000 | -25.4% | 73,296 | +2.5% | 0.00% | – |
| Q1 2019 | $2,010,000 | +15.5% | 71,531 | +0.6% | 0.00% | – |
| Q4 2018 | $1,740,000 | -34.6% | 71,114 | -0.6% | 0.00% | -100.0% |
| Q3 2018 | $2,659,000 | +118.1% | 71,568 | +21.8% | 0.00% | – |
| Q2 2018 | $1,219,000 | +215.8% | 58,777 | +119.4% | 0.00% | – |
| Q1 2018 | $386,000 | +21.4% | 26,791 | +27.9% | 0.00% | – |
| Q4 2017 | $318,000 | +58.2% | 20,941 | +0.2% | 0.00% | – |
| Q3 2017 | $201,000 | +11.0% | 20,897 | -1.0% | 0.00% | – |
| Q2 2017 | $181,000 | -64.0% | 21,107 | -62.7% | 0.00% | – |
| Q1 2017 | $503,000 | -34.2% | 56,517 | -18.0% | 0.00% | – |
| Q4 2016 | $765,000 | -30.3% | 68,882 | +6.7% | 0.00% | – |
| Q3 2016 | $1,097,000 | -24.2% | 64,552 | -2.9% | 0.00% | – |
| Q2 2016 | $1,447,000 | +73.5% | 66,463 | +52.7% | 0.00% | – |
| Q1 2016 | $834,000 | -28.9% | 43,531 | +4.0% | 0.00% | – |
| Q4 2015 | $1,173,000 | +64.1% | 41,856 | +42.7% | 0.00% | – |
| Q3 2015 | $715,000 | – | 29,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 783,066 | $30,814,000 | 5.13% |
| Soleus Capital Management, L.P. | 773,694 | $30,444,859 | 3.15% |
| RK Capital | 335,400 | $13,197,990 | 2.90% |
| Capital Impact Advisors, LLC | 19,390 | $762,997 | 0.94% |
| Ranger Investment Management | 205,692 | $8,093,980 | 0.54% |
| Bares Capital Management | 317,000 | $12,473,950 | 0.44% |
| Hillsdale Investment Management Inc. | 109,100 | $4,293,085 | 0.37% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,007 | $1,456,225 | 0.26% |
| Riverwater Partners LLC | 6,234 | $245,308 | 0.22% |
| RICE HALL JAMES & ASSOCIATES, LLC | 72,271 | $2,843,864 | 0.16% |